Strategikon Pharma Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 35

Employees

  • Latest Deal Type
  • Debt

  • Latest Deal Amount
  • $2.29M

  • Investors
  • 14

Strategikon Pharma General Information

Description

Operator of a cloud-based platform intended to cater to the needs of business management of pharmaceutical clinical trials. The company's platform offers planning, outsourcing, and financial and contract management of clinical trials, enabling businesses to generate insights and analytics into their clinical portfolios and providers' performance.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1 Sansome Street
  • 35th Floor, Post Mail Box Number 40621
  • San Francisco, CA 94104
  • United States
+1 (415)
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • 1 Sansome Street
  • 35th Floor, Post Mail Box Number 40621
  • San Francisco, CA 94104
  • United States
+1 (415)

Strategikon Pharma Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Strategikon Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Debt - General 21-Nov-2025 $2.29M Completed Generating Revenue
7. General Corporate Purpose 10-Jun-2025 Completed Generating Revenue
6. Later Stage VC (Series A1) 01-Mar-2024 Completed Generating Revenue
5. Later Stage VC (Series A) 04-Oct-2023 Completed Generating Revenue
4. Grant 13-Apr-2023 Completed Generating Revenue
3. Early Stage VC 06-Apr-2021 Completed Generating Revenue
2. Seed Round 09-Dec-2020 $6.5M $6.5M Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2020 Completed Generating Revenue
To view Strategikon Pharma’s complete valuation and funding history, request access »

Strategikon Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-3
Series A-2
Series A1
Series A 5,007,790 $0.001000 $0.9 $0.9 1x $0.9 14.83%
Seed 9,911,589 $0.001000 $0.72 $0.72 1x $0.72 29.35%
To view Strategikon Pharma’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Strategikon Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a cloud-based platform intended to cater to the needs of business management of pharmaceutical clinical tria
Other Pharmaceuticals and Biotechnology
San Francisco, CA
35 As of 2025

San Antonio, TX
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Strategikon Pharma Competitors (1)

One of Strategikon Pharma’s competitors is RealTime eClinical Solutions, a Private Equity-Backed company based in San Antonio, TX.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
RealTime eClinical Solutions Private Equity-Backed San Antonio, TX
You’re viewing 1 of 1 competitors. Get the full list »

Strategikon Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Strategikon Pharma Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Debiopharm Innovation Fund Corporate Venture Capital Minority
Golden Seeds Ventures Venture Capital Minority
Venture Madness Accelerator/Incubator
HearstLab Corporate Venture Capital Minority
NuFund Venture Group Angel Group Minority
You’re viewing 5 of 14 investors. Get the full list »

Strategikon Pharma FAQs

  • When was Strategikon Pharma founded?

    Strategikon Pharma was founded in 2017.

  • Where is Strategikon Pharma headquartered?

    Strategikon Pharma is headquartered in San Francisco, CA.

  • What is the size of Strategikon Pharma?

    Strategikon Pharma has 35 total employees.

  • What industry is Strategikon Pharma in?

    Strategikon Pharma’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Strategikon Pharma a private or public company?

    Strategikon Pharma is a Private company.

  • What is Strategikon Pharma’s current revenue?

    The current revenue for Strategikon Pharma is .

  • How much funding has Strategikon Pharma raised over time?

    Strategikon Pharma has raised $23.3M.

  • Who are Strategikon Pharma’s investors?

    Debiopharm Innovation Fund, Golden Seeds Ventures, Venture Madness, HearstLab, and NuFund Venture Group are 5 of 14 investors who have invested in Strategikon Pharma.

  • Who are Strategikon Pharma’s competitors?

    RealTime eClinical Solutions is a competitor of Strategikon Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process